CF
39
3
FRT
51
-4
TXN
36
-12
HPE
16
2
HOG
26
-16
UAL
58
2
EQIX
62
-3
CTAS
53
4
PGR
72
-5
PFE
19
-6
STX
45
3
GILD
28
-4
ETN
82
-2
URI
68
10
FSLR
55
-3
PSX
42
-12
NOV
55
-3
LNC
43
-3
HSY
41
-2
EL
46
-6
CF
39
3
FRT
51
-4
TXN
36
-12
HPE
16
2
HOG
26
-16
UAL
58
2
EQIX
62
-3
CTAS
53
4
PGR
72
-5
PFE
19
-6
STX
45
3
GILD
28
-4
ETN
82
-2
URI
68
10
FSLR
55
-3
PSX
42
-12
NOV
55
-3
LNC
43
-3
HSY
41
-2
EL
46
-6
Financhill
Back

Pliant Therapeutics Vs. Catalyst Pharmaceuticals Industry Stock Comparison

Sell
19

PLRX
Pliant Therapeutics

Last Price:
11.89
Seasonality Move:
40.29%
Sell
41

CPRX
Catalyst Pharmaceuticals

Last Price:
14.69
Seasonality Move:
2.11%
Sell
19
Pliant Therapeutics (PLRX) is a Sell

Is Pliant Therapeutics a Buy, Sell or Hold?

  • The current Pliant Therapeutics [PLRX] share price is $11.88. The Score for PLRX is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • PLRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
41
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $14.68. The Score for CPRX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PLRX Stock Price Chart

What is Pliant Therapeutics's stock price today?

  • The Pliant Therapeutics share price today is $11.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $14.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing selling pressure, which indicates risk of future bearish movement.

PLRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.82 Sell
Relative Strength Index (14 RSI): 28.07 Sell
Chaikin Money Flow: 572527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.82 - 14.9) Sell
Bollinger Bands (100): (14.18 - 17.6) Sell

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 41.25 Sell
Chaikin Money Flow: -560167 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 15.98) Sell
Bollinger Bands (100): (14.04 - 16.2) Sell

PLRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.46 Sell
20-day SMA: 13.68 Sell
50-day SMA: 14.85 Sell
200-day SMA: 16.03 Sell
8-day EMA: 12.54 Sell
20-day EMA: 13.39 Sell
50-day EMA: 14.51 Sell
200-day EMA: 16.57 Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.21 Sell
20-day SMA: 15.4 Sell
50-day SMA: 15.47 Sell
200-day SMA: 14.2 Buy
8-day EMA: 15.1 Sell
20-day EMA: 15.36 Sell
50-day EMA: 15.35 Sell
200-day EMA: 14.58 Buy

Pliant Therapeutics Earnings Growth & PLRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.39 per share, and a decrease next year of $0.25 per share.

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $0.43 per share.

Pliant Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):